Ipsen to Acquire ImCheck Therapeutics to Boost Immuno-Oncology Pipeline

Read more

FDA Approves GSK’s Blenrep Combo for Relapsed or Refractory Multiple Myeloma

Read more

Takeda and Innovent Partner in $1.2 Billion Deal to Advance Late-Stage Cancer Drugs Globally

Read more

Ventus Therapeutics Teams Up with Genentech for AI-Driven Drug Discovery Collaboration

Read more

Roche’s Tecentriq Shows Survival Benefit in ctDNA-Guided Bladder Cancer Trial

Read more

EMA Backs Approval of GSK’s Shingrix in New Prefilled Syringe Format

Read more

Just announced: AI in Drug Discovery 2026 agenda

Read more

FDA Approves Glaukos’ Epioxa, First Incision-Free Drug for Keratoconus

Read more

Roche’s Tecentriq Extends Survival in Bladder Cancer Using ctDNA-Guided Approach

Read more

FDA Approves Roche’s Gazyva for Lupus Nephritis with Streamlined Dosing

Read more